Skip to main content

Publications

featured publications

  • Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A.

    PloS one

    Authors: Delphine Bachelet, Thilo Albert, Cyprien Mbogning, Signe Hässler, Yuan Zhang, Stephan Schultze-Strasser, Yohann Repessé, Julie Rayes, Anna Pavlova, Behnaz Pezeshkpoor, Kerstin Liphardt, Julie E Davidson, Agnès Hincelin-Méry, Pierre Dönnes, Sébastien Lacroix-Desmazes, Christoph Königs, Johannes Oldenburg, Philippe Broët

  • Identification of Potential Novel Interacting Partners for Coagulation Factor XIII B (FXIII-B) Subunit, a Protein Associated with a Rare Bleeding Disorder.

    International journal of molecular sciences

    Authors: Sneha Singh, Mohammad Suhail Akhter, Johannes Dodt, Peter Volkers, Andreas Reuter, Christoph Reinhart, Christoph Krettler, Johannes Oldenburg, Arijit Biswas

  • Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A: the A-SURE study.

    BMJ open

    Authors: Johannes Oldenburg, Charles R M Hay, Víctor Jiménez-Yuste, Flora Peyvandi, Jean-François Schved, Johan Szamosi, Bent Winding, Stefan Lethagen

  • F8 Inversions at Xq28 Causing Hemophilia A Are Associated With Specific Methylation Changes: Implication for Molecular Epigenetic Diagnosis.

    Frontiers in genetics

    Authors: Muhammad Ahmer Jamil, Amit Sharma, Nicole Nuesgen, Behnaz Pezeshkpoor, André Heimbach, Anne Pavlova, Johannes Oldenburg, Osman El-Maarri

  • Estimation of Nuwiq (simoctocog alfa) activity using one-stage and chromogenic assays-Results from an international comparative field study.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Stefan Tiefenbacher, Manuela Albisetti, Peter Baker, Guenther Kappert, Steve Kitchen, Johanna A Kremer Hovinga, Claire Pouplard, Ute Scholz, Catherine Ternisien, Carin Borgvall, Tiago Vicente, Larisa Belyanskaya, Olaf Walter, Johannes Oldenburg

  • The role of variant alleles of the mannose-binding lectin in the inhibitor development in severe hemophilia A.

    Thrombosis research

    Authors: Gudrun Ulrich-Merzenich, Annekristin Hausen, Heike Zeitler, Georg Goldmann, Johannes Oldenburg, Anna Pavlova

  • The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Manuel Carcao, Carmen Escuriola-Ettingshausen, Elena Santagostino, Johannes Oldenburg, Ri Liesner, Beatrice Nolan, Angelika Bátorová, Saturnino Haya, Guy Young

  • [Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren].

    Hamostaseologie

    Authors: Hermann Eichler, Manuela Albisetti Pedroni, Susan Halimeh, Christoph Königs, Florian Langer, Wolfgang Miesbach, Johannes Oldenburg, Ute Scholz, Werner Streif, Robert Klamroth

  • Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS).

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Johnny Mahlangu, Johannes Oldenburg, Michael U Callaghan, Midori Shima, Maria Elisa Mancuso, Peter Trask, Michael Recht, Claudia Garcia, Renchi Yang, Michaela Lehle, Harrison Macharia, Elina Asikanius, Gallia G Levy, Rebecca Kruse-Jarres, Sylvia von Mackensen

  • Disruption of Structural Disulfides of Coagulation FXIII-B Subunit; Functional Implications for a Rare Bleeding Disorder.

    International journal of molecular sciences

    Authors: Sneha Singh, Mohammad Suhail Akhter, Johannes Dodt, Amit Sharma, Senthilvelrajan Kaniyappan, Hamideh Yadegari, Vytautas Ivaskevicius, Johannes Oldenburg, Arijit Biswas